Figure 1

<p>(A) Malaria monitoring and evaluation framework and illustrative data types. Source: adapted from <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000400#pmed.1000400-Roll2" target="_blank">[3]</a>. (B) Evolving malaria monitoring and evaluation framework with emphasis on transmission. Image credit: Fusión Creativa.</p

Program activities and methods for transmission reduction in populations.

a<p>Note that mass drug administration is controversial for a variety of reasons but is presented here for completeness sake as it has been used to some benefit in the past (see also <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000400#pmed.1000400-The4" target="_blank">[25]</a>).</p>b<p>See also <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000400#pmed.1000400-The1" target="_blank">[11]</a> and <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000400#pmed.1000400-The4" target="_blank">[25]</a>.</p>c<p>See also <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000400#pmed.1000400-The1" target="_blank">[11]</a> and <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000400#pmed.1000400-Corran1" target="_blank">[44]</a>.</p>d<p>See also <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000400#pmed.1000400-The2" target="_blank">[12]</a>.</p><p><i>Pf, P. falciparum</i>; <i>Pv, P. vivax.</i></p